Investing
Vertex Pharmaceuticals stock gains for second consecutive day amid bullish market
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect
On Tuesday, Vertex Pharmaceuticals Inc (NASDAQ:).’s shares saw a modest gain of 0.47% to close at $369.38 per piece, marking the second day of consecutive gains in a generally bullish market. This comes as both the and the reported increases of 0.73% and 0.62%, respectively.
Despite these gains, Vertex trailed behind competitors such as AbbVie Inc (NYSE:)., Krystal Biotech (NASDAQ:) Inc., and Arcturus Therapeutics (NASDAQ:) Holdings Inc., which reported more substantial gains of 1.09%, 4.17%, and 2.74% respectively.
The trading volume for Vertex on Tuesday was 996,332, surpassing its average 50-day trading volume of 961,076. However, despite the recent uptick, the company’s stock ended the day $6.55 short of its 52-week high of $375.93, a peak that was achieved in October of the previous year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
-
Make Money6 days ago
10 Ways to Make Money As a Graphic Designer
-
Personal Finance5 days ago
If you are 60 years old, new 401(k) rules could save you money
-
Investing6 days ago
Could Easier Cancellations Build Customer Loyalty?
-
Investing4 days ago
Bank regulator gives BlackRock new deadline on bank stakes, Bloomberg reports By Reuters
-
Side Hustles6 days ago
Trump’s 2025 Inaugural Committee Raises Record $170 Million
-
Side Hustles3 days ago
LA Rental Prices Skyrocketing Despite Price Gouging Laws
-
Side Hustles4 days ago
Former Zillow Execs Target $1.3T Market
-
Investing5 days ago
It’s Time to Rewrite Your Company’s Values — Here’s How